318 related articles for article (PubMed ID: 32777431)
1. Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data.
Thresher A; Foster R; Ponting DJ; Stalford SA; Tennant RE; Thomas R
Regul Toxicol Pharmacol; 2020 Oct; 116():104749. PubMed ID: 32777431
[TBL] [Abstract][Full Text] [Related]
2. Mutagenic impurities in pharmaceuticals: A critical assessment of the cohort of concern with a focus on N-nitrosamines.
Snodin DJ
Regul Toxicol Pharmacol; 2023 Jun; 141():105403. PubMed ID: 37116739
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency.
Snodin DJ; Trejo-Martin A; Ponting DJ; Smith GF; Czich A; Cross K; Custer L; Elloway J; Greene N; Kalgutkar AS; Stalford SA; Tennant RE; Vock E; Zalewski A; Ziegler V; Dobo KL
Chem Res Toxicol; 2024 Feb; 37(2):181-198. PubMed ID: 38316048
[TBL] [Abstract][Full Text] [Related]
4. Ames test study designs for nitrosamine mutagenicity testing: qualitative and quantitative analysis of key assay parameters.
Thomas DN; Wills JW; Tracey H; Baldwin SJ; Burman M; Williams AN; Harte DSG; Buckley RA; Lynch AM
Mutagenesis; 2024 Mar; 39(2):78-95. PubMed ID: 38112628
[TBL] [Abstract][Full Text] [Related]
5. The mutagenicity of 45 nitrosamines in the Salmonella typhimurium.
Andrews AW; Lijinsky W
Teratog Carcinog Mutagen; 1980; 1(3):295-303. PubMed ID: 6119819
[TBL] [Abstract][Full Text] [Related]
6. Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines.
Trejo-Martin A; Bercu JP; Thresher A; Tennant RE; Thomas RF; Cross K; Czich A; Waese K; Nicolette JJ; Murray J; Sonders P; Kondratiuk A; Cheung JR; Thomas D; Lynch A; Harvey J; Glowienke S; Custer L; Escobar PA
Regul Toxicol Pharmacol; 2022 Nov; 135():105247. PubMed ID: 35998738
[TBL] [Abstract][Full Text] [Related]
7. Potentially mutagenic impurities: analysis of structural classes and carcinogenic potencies of chemical intermediates in pharmaceutical syntheses supports alternative methods to the default TTC for calculating safe levels of impurities.
Galloway SM; Vijayaraj Reddy M; McGettigan K; Gealy R; Bercu J
Regul Toxicol Pharmacol; 2013 Aug; 66(3):326-35. PubMed ID: 23688841
[TBL] [Abstract][Full Text] [Related]
8. Utilisation of parametric methods to improve percentile-based estimates for the carcinogenic potency of nitrosamines.
Thomas R; Thresher A; Ponting DJ
Regul Toxicol Pharmacol; 2021 Apr; 121():104875. PubMed ID: 33556416
[TBL] [Abstract][Full Text] [Related]
9. Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA).
Kruhlak NL; Schmidt M; Froetschl R; Graber S; Haas B; Horne I; Horne S; King ST; Koval IA; Kumaran G; Langenkamp A; McGovern TJ; Peryea T; Sanh A; Siqueira Ferreira A; van Aerts L; Vespa A; Whomsley R
Regul Toxicol Pharmacol; 2024 Jun; 150():105640. PubMed ID: 38754805
[TBL] [Abstract][Full Text] [Related]
10. Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA).
Bercu JP; Masuda-Herrera M; Johnson G; Czich A; Glowienke S; Kenyon M; Thomas R; Ponting DJ; White A; Cross K; Waechter F; Rodrigues MAC
Regul Toxicol Pharmacol; 2021 Jul; 123():104926. PubMed ID: 33862169
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic impurities in pharmaceuticals: a critique of the derivation of the cancer TTC (Threshold of Toxicological Concern) and recommendations for structural-class-based limits.
Snodin DJ; McCrossen SD
Regul Toxicol Pharmacol; 2013 Nov; 67(2):299-316. PubMed ID: 23988886
[TBL] [Abstract][Full Text] [Related]
12. A deep dive into historical Ames study data for N-nitrosamine compounds.
Tennant RE; Ponting DJ; Thresher A
Regul Toxicol Pharmacol; 2023 Sep; 143():105460. PubMed ID: 37495012
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the carcinogenicity and mutagenicity of nitrosamines in a hepatocyte-mediated mutagenicity assay.
Jones CA; Marlino PJ; Lijinsky W; Huberman E
Carcinogenesis; 1981; 2(10):1075-7. PubMed ID: 7296760
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s.
Li X; He X; Le Y; Guo X; Bryant MS; Atrakchi AH; McGovern TJ; Davis-Bruno KL; Keire DA; Heflich RH; Mei N
Arch Toxicol; 2022 Nov; 96(11):3077-3089. PubMed ID: 35882637
[TBL] [Abstract][Full Text] [Related]
15. Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product
Dobo KL; Kenyon MO; Dirat O; Engel M; Fleetwood A; Martin M; Mattano S; Musso A; McWilliams JC; Papanikolaou A; Parris P; Whritenour J; Yu S; Kalgutkar AS
Chem Res Toxicol; 2022 Mar; 35(3):475-489. PubMed ID: 35212515
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity assessments of N-nitrosoethylisopropylamine (NEIPA) and N-nitrosodiisopropylamine (NDIPA) in the C57BL/6J mouse.
Ye Q; Geng X; Jiang H; Qin C; Wu H; Wang S; Wen H
Mutat Res Genet Toxicol Environ Mutagen; 2024; 896():503763. PubMed ID: 38821676
[TBL] [Abstract][Full Text] [Related]
17. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
Ashby J; Paton D
Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
[TBL] [Abstract][Full Text] [Related]
18. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
19. Predicting rodent carcinogenicity from mutagenic potency measured in the Ames Salmonella assay.
Fetterman BA; Kim BS; Margolin BH; Schildcrout JS; Smith MG; Wagner SM; Zeiger E
Environ Mol Mutagen; 1997; 29(3):312-22. PubMed ID: 9142175
[TBL] [Abstract][Full Text] [Related]
20. Genotoxic and carcinogenic effects of gastrointestinal drugs.
Brambilla G; Mattioli F; Martelli A
Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
